910
Participants
Start Date
April 1, 2024
Primary Completion Date
June 9, 2025
Study Completion Date
June 9, 2025
Quadrivalent Influenza mRNA Vaccine MRT5421
Pharmaceutical form:solution in a vial-Route of administration:Intramuscular injection
Quadrivalent Influenza mRNA Vaccine MRT5424
Pharmaceutical form:solution in a vial-Route of administration:Intramuscular injection
Quadrivalent Influenza mRNA Vaccine MRT5429
Pharmaceutical form:solution in a vial-Route of administration:Intramuscular Injection
Quadrivalent Influenza Standard Dose Vaccine
Pharmaceutical form: suspension for injection in prefilled syringe -Route of administration:Intramuscular injection
Quadrivalent Influenza High-Dose Vaccine
Pharmaceutical form:suspension for injection in pre filled syringe -Route of administration:Intramuscular injection
Quadrivalent Recombinant Influenza Vaccine
Pharmaceutical form:suspension for injection in pre filled syringe-Route of administration:Intramuscular injection
Rochester Clinical Research. Inc.- Site Number : 8400005, Rochester
Investigational Site Number : 3400001, San Pedro Sula
Coastal Carolina Research Center- Site Number : 8400014, North Charleston
SIMEDHealth, LLC- Site Number : 8400011, Gainesville
Indago Research and Health Center- Site Number : 8400032, Hialeah
Cenexel Research Centers of America- Site Number : 8400037, Hollywood
Suncoast Research Group, LLC- Site Number : 8400015, Miami
AMR Knoxville- Site Number : 8400043, Knoxville
AMR Lexington- Site Number : 8400042, Lexington
Brengle Family Medicine Site Number : 8400045, Indianapolis
The Alliance for Multispecialty Research - KCM, LLC- Site Number : 8400034, Kansas City
Velocity Clinical Research, Omaha- Site Number : 8400008, Omaha
Velocity Clinical Research Norfolk- Site Number : 8400046, Norfolk
Velocity Clinical Research- New Orleans Site Number : 8400053, New Orleans
Clinical Trials of Texas, Inc. - PPDS- Site Number : 8400029, San Antonio
Cenexel JBR- Site Number : 8400051, Salt Lake City
Long Beach Clinical Trials Site Number : 8400013, Long Beach
California Research Foundation Site Number : 8400038, San Diego
Accel Clinical Research-Deland Clinical Research Unit- Site Number : 8400001, DeLand
Investigational Site Number : 6300002, Barrio Sabana
Sanofi Pasteur, a Sanofi Company
INDUSTRY